MedPath

Clinical effectiveness of Kasthuri Karuppu in the management of Eraippu Noi (Bronchial Asthma)

Phase 2
Conditions
Health Condition 1: J454- Moderate persistent asthma
Registration Number
CTRI/2024/01/061028
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age between 18 and 60years

Sex: Male ,Female &Transgender

Patients who are willing to undergo Pulmonary Function Test (FEV1-50-80%)

will be taken

Patients who are willing to undergo radiological investigations and provide

blood sample for lab investigations

Exclusion Criteria

K/C/O Restrictive Lung diseases

K/C/O Pulmonary tuberculosis

K/C/O Emphysema

K/C/O Pleural effusion

K/C/O Pneumothorax

K/C/O Cardiac diseases

K/C/O Renal diseases

Pregnancy

Lactation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome is assessed by comparing the lung volumes and capacities in pulmonary function tests along with graph PFT of obstructive pattern before and after treatment <br/ ><br>Timepoint: 15th day <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Secondary outcome is assessed by comparing the improvement of clinical symptoms of <br/ ><br>Eraippu noi patients by using Asthma Control Questionairre and laboratory parameters such as IgE, <br/ ><br>Absolute Eosinophil Count (AEC),Erythrocyte sedimentation rate (ESR) before and after treatmentTimepoint: 15th day
© Copyright 2025. All Rights Reserved by MedPath